Persistent Asset Partners »

Bridgebio Pharma shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $102k 60k 1.70

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Bridgebio Pharma

D. E. Shaw & Co
Franklin Resources
OZ Management
Invesco
BlackRock
Nuveen
CSS
Alberta Investment Management Corporation
Calamos Advisors
Ameriprise Financial
Wolverine Asset Management
SSI Investment Management
Bank of America Corporation
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc

View all funds holding Bridgebio Pharma